1. Araujo FG, Remington JS: Toxoplasmosis in immunocompromised patients. European Journal of Clinical Microbiology and Infectious Diseases 1987, 6: 1–2.
2. Mills J:Pneumocystis carinii andToxoplasma gondii infections in patients with AIDS. Review of Infectious Diseases 1986, 8: 1001–1011.
3. Remington JS, Desmonts G: Toxoplasmosis. In: Remington JS, Klein JO (ed): Infectious Diseases of the fetus and newborn infants. W.B. Saunders, Philadelphia, 1990, p. 89–195.
4. Eyles DE, Coleman M: Synergistic effect of sulfadiazine and daraprin against experimental toxoplasmosis in the mouse. Antibiotics and Chemotherapy 1953, 3: 483–490.
5. Brooks RG, Remington JS, Luft BJ: Drugs used in the treatment of toxoplasmosis. In: Peterson PK, Verhoef J (ed): The Antimicrobial Agents Annual. Volume 2. Elsevier, Amsterdam, 1987, p. 297–306.